PE20121472A1 - Combinacion de farmacos con teobromina y su uso en terapia - Google Patents

Combinacion de farmacos con teobromina y su uso en terapia

Info

Publication number
PE20121472A1
PE20121472A1 PE2012000650A PE2012000650A PE20121472A1 PE 20121472 A1 PE20121472 A1 PE 20121472A1 PE 2012000650 A PE2012000650 A PE 2012000650A PE 2012000650 A PE2012000650 A PE 2012000650A PE 20121472 A1 PE20121472 A1 PE 20121472A1
Authority
PE
Peru
Prior art keywords
combination
theobromine
drugs
therapy
propoxycphene
Prior art date
Application number
PE2012000650A
Other languages
English (en)
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PE20121472A1 publication Critical patent/PE20121472A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PE2012000650A 2009-11-13 2010-11-12 Combinacion de farmacos con teobromina y su uso en terapia PE20121472A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
PE20121472A1 true PE20121472A1 (es) 2012-11-30

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000650A PE20121472A1 (es) 2009-11-13 2010-11-12 Combinacion de farmacos con teobromina y su uso en terapia

Country Status (19)

Country Link
EP (1) EP2498776A1 (enExample)
JP (2) JP2013510842A (enExample)
CN (1) CN102740853B (enExample)
AU (1) AU2010317668C1 (enExample)
BR (1) BR112012011224A2 (enExample)
CA (1) CA2780704C (enExample)
CO (1) CO6551745A2 (enExample)
EC (2) ECSP12011892A (enExample)
GB (1) GB0919893D0 (enExample)
IL (1) IL219769A0 (enExample)
MX (1) MX2012005538A (enExample)
NZ (1) NZ599957A (enExample)
PE (1) PE20121472A1 (enExample)
PH (1) PH12012500955A1 (enExample)
RU (1) RU2587329C2 (enExample)
SG (1) SG10201407496SA (enExample)
UA (1) UA105940C2 (enExample)
WO (1) WO2011058374A1 (enExample)
ZA (1) ZA201204247B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108064T1 (de) * 1987-10-08 1994-07-15 Andor Bilas Stoffgemisch zur stabilisierung der stoffwechsel- lage.
CA2170488A1 (en) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
ES2528384T3 (es) * 2001-12-12 2015-02-09 The Government Of The United States Of America, As Represented By The Secretary Department Of Healt Métodos de utilización de inhibidores del receptor de adenosina para potenciar la respuesta inmunitaria y la inflamación
AU2004216550B2 (en) * 2003-02-28 2010-06-03 Ym Biosciences Inc. Opioid delivery system
CN1593451A (zh) * 2003-09-12 2005-03-16 杨喜鸿 促进男性勃起的外用药物
JPWO2006064780A1 (ja) * 2004-12-14 2008-06-12 塩野義製薬株式会社 便秘治療剤
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물

Also Published As

Publication number Publication date
CA2780704A1 (en) 2011-05-19
ZA201204247B (en) 2013-02-27
EP2498776A1 (en) 2012-09-19
CA2780704C (en) 2018-07-17
AU2010317668C1 (en) 2016-02-11
IL219769A0 (en) 2012-07-31
RU2012124063A (ru) 2013-12-20
CN102740853A (zh) 2012-10-17
JP2013510842A (ja) 2013-03-28
RU2587329C2 (ru) 2016-06-20
UA105940C2 (uk) 2014-07-10
GB0919893D0 (en) 2009-12-30
WO2011058374A1 (en) 2011-05-19
CN102740853B (zh) 2015-04-08
SG10201407496SA (en) 2015-02-27
ECSP12011892A (es) 2012-09-28
CO6551745A2 (es) 2012-10-31
NZ599957A (en) 2014-05-30
AU2010317668A1 (en) 2012-06-07
JP2016041748A (ja) 2016-03-31
BR112012011224A2 (pt) 2017-03-01
AU2010317668B2 (en) 2015-01-22
ECSP12011893A (es) 2012-10-30
PH12012500955A1 (en) 2013-01-07
MX2012005538A (es) 2012-09-28

Similar Documents

Publication Publication Date Title
MX2012007769A (es) Muestreo aleatorio para adquisiciones geofisicas.
CL2014002754A1 (es) Forma de dosis de liberación controlada solida que comprende un nucleo con una primera porcion de un analgesico opioide y una cubierta que encierra el nucleo y comprende una segunda porcion del analgesico opioide; metodo de preparacion; uso en el tratamiento del dolor. (divisional de solicitud n°1450-2014).
AU347998S (en) Electronic device
AU345940S (en) Electronic device
AU349749S (en) Display structure
AU336886S (en) Electronic device
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
USD761311S1 (en) Display screen or portion thereof with graphical user interface
MX2013007622A (es) Combinacion de un agonista opioide y un antagonista opioide en el tratamiento de la enfermedad de parkinson.
AU349050S (en) Telephone
PE20121472A1 (es) Combinacion de farmacos con teobromina y su uso en terapia
PH12012501200A1 (en) Therapeutic combinations of theobromine and an antihistamine
AU335193S (en) Speaker
UA108993C2 (en) MEDICINAL COMBINATION WITH THEOBROMINE AND ITS APPLICATION IN Cough
AU337555S (en) Tablet
GB2535954A (en) A support structure
CO6541630A2 (es) Combinación teobromina con un descongestivo y su uso para el tratamiento de la tos
AU335160S (en) Speaker
AU325789S (en) Tube
UA89010C2 (ru) Комбинированное обезболивающее средство на основе кеторолака и дротаверина
AU337509S (en) Key holder
CA143686S (en) Buccal medication delivery device adapter
Darabi et al. THE EFFECT OF INTRA-AMYGDALA MEMANTINE ADMINISTRATION ON MORPHINE WITHDRAWAL SYNDROME SIGNS IN MICE
AU333838S (en) Oestrus detector
AU333839S (en) Oestrus detector

Legal Events

Date Code Title Description
FC Refusal